Trinity Biotech (TRIB) Return on Sales (2009 - 2024)

Trinity Biotech's Return on Sales history runs 16 years deep, the most recent figure standing at 0.01% for Q4 2024.

• In Q4 2024, Return on Sales fell 1.0% year-over-year to 0.01%; the TTM figure through Dec 2024 stood at 0.0% (changed 0.0% YoY), while the FY2025 annual figure was 0.01%, down 1.0% from the prior year.
• Return on Sales came in at 0.01% for Q4 2024 at Trinity Biotech, down from 0.0% in the prior quarter.
• In the past five years, Return on Sales ranged from a high of 0.0% in Q3 2020 to a low of 0.01% in Q2 2023.
• A 5-year average of 0.0% and a median of 0.0% in 2023 frame the typical range for Return on Sales.
• Across the five-year window, Return on Sales retreated 1 bps in 2022 and increased 1 bps in 2024, its largest moves.
• Trinity Biotech's Return on Sales stood at 0.0% in 2020, then plunged by 155 bps to 0.0% in 2021, then tumbled by 285 bps to 0.01% in 2022, then soared by 40 bps to 0.0% in 2023, then plunged by 148 bps to 0.01% in 2024.
• According to Business Quant data, Return on Sales over the past three periods registered 0.01%, 0.0%, and 0.0% for Q4 2024, Q3 2024, and Q2 2024 respectively.

Peer Comparison